Immunology Investor Event

Abbreviations (Part 2) oral anti H1 OX40L PN PoM Q2W Q4W QW RA RIPK1 RRR SJS SLE SOB SoC TAS Teff TH2, (TH17, TH22,...) Tmem TNF TNFR Treg TSLP UAS7 UC Oral H1 antihistamines OX40 ligand Prurigo Nodularis Proof of Mechanism Once every two-week dosing Once every four-week dosing Once weekly dosing Rheumatoid Arthritis Receptor-Interacting serine/threonine-Protein Kinase 1 Relative Risk Reduction Sjögren's Syndrome Systemic Lupus Erythematosus Shortness of breath. Standard of Care Therapeutic Areas Effector T cells T helper 2 cells Memory T cells tumour necrosis factor TNF receptor Regulatory T cells Thymic stromal lymphopoietin Urticaria Activity Score Ulcerative Colitis 57 Immunology Investor Event sanofi

View entire presentation